Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma.

Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma. Leuk Res. 2013 Jul; 37(7):829-37.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.